No significant difference in the elevation of CD4+ cell count was observed between the subgroups in patients with the BC genotype (median, 219.3 cells/mm3 in the DT group vs. 231.5 cells/mm3 in the TT group) (Figures 4F,G). Here, CD4 is linked to breast cancer.